Download presentation
Presentation is loading. Please wait.
Published byNeuza do Amaral Lameira Modified over 6 years ago
1
Volume 45, Issue 4, Pages 420-429 (April 2004)
Darifenacin, an M3 Selective Receptor Antagonist, is an Effective and Well-Tolerated Once-Daily Treatment for Overactive Bladder F Haab, L Stewart, P Dwyer European Urology Volume 45, Issue 4, Pages (April 2004) DOI: /j.eururo
2
Fig. 1 Participant flow. European Urology , DOI: ( /j.eururo )
3
Fig. 2 Median reduction from baseline in incontinence episodes per week at weeks 2, 6, and 12. European Urology , DOI: ( /j.eururo )
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.